Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2 Inhibitors in Diabetic Heart Failure Patients Undergoing Ablation
NCT03977116Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) and diabetes mellitus (DM) (2 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoints: All Cause Deaths at 12 months, Cardiac Deaths at 12 months and 1 more. Started Jan 2017; status: completed.
02
Conditions
heart failure (HF)diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03977116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977116.